Nov 20, 2019 8:00am EST

Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update

Oct 24, 2019 4:15pm EDT

Cancer Genetics, Inc. Announces Strategic Transactions

Oct 24, 2019 8:30am EDT

Cancer Genetics Announces 1-for-30 Reverse Stock Split

Aug 20, 2019 8:00am EDT

Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update

Jul 15, 2019 4:22pm EDT

Cancer Genetics, Inc. Announces Strategic Transactions

May 20, 2019 5:00pm EDT

Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update

Apr 16, 2019 7:00am EDT

Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates

Jan 31, 2019 4:01pm EST

Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock

Jan 28, 2019 10:33pm EST

Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock

Jan 28, 2019 4:00pm EST

Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock